MARKET

GENFF

GENFF

Genflow Biosciences
OTCMQB
0.040
NaN%
Closed 09:30 06/09 EDT
OPEN
--
PREV CLOSE
0.040
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.065
52 WEEK LOW
0.010
MARKET CAP
22.66M
P/E (TTM)
-9.0909
1D
5D
1M
3M
1Y
5Y
1D
Genflow Biosciences non-executive director Peter King-Lewis steps down from board
PUBT · 5d ago
Genflow Biosciences publishes 2025 annual report
PUBT · 04/30 15:53
Genflow Biosciences announces annual report availability for year ended Dec. 31, 2025
PUBT · 04/30 13:07
Genflow expands confidentiality agreements with Tier-1 animal health companies for canine gene therapy
PUBT · 04/28 06:21
Genflow Biosciences enters LNP delivery technology collaboration with Acuitas Therapeutics
PUBT · 04/20 06:00
Genflow says SIRT6 variant patent publication targets frailty, sarcopenia muscle loss
PUBT · 04/13 06:17
Genflow Biosciences CEO Eric Leire and Chairman Gad Berdugo subscribe for new shares at 1.9p
Reuters · 03/05 12:06
Genflow Biosciences Reports Positive Interim Results for SIRT6 Gene Therapy in Aged Dogs
Reuters · 02/12 07:00
More
About GENFF
Genflow Biosciences Plc is a United Kingdom-based biotechnology company. The Company is engaged in developing gene therapies designed to target the aging process and to reduce and delay the incidence of age-related diseases, which is done through therapeutics targeting aging in humans by using adeno-associated virus (AAV) vectors to deliver copies of the Sirtuin-6 (SIRT6) gene variant that is found in centenarians into cells. The Company's product pipeline includes GF-1002, GF-1003, GF-1004, GF-1005 and GF-1006. GF-4001. GF-1002 is a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. GF-1004 is a non-human version of GF-1002 anti-ageing gene therapy developed for veterinary use (dogs). GF-1003 is a formulation of an adeno-associated viral vector-based gene therapy. The Company has operations in the United Kingdom and Belgium.

Webull offers Genflow Biosciences PLC stock information, including OTCMQB: GENFF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENFF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GENFF stock methods without spending real money on the virtual paper trading platform.